Benign Uterine Disease
Conditions
Keywords
Bladder symptoms, Sexual function, Quality of life, Simple hysterectomy
Brief summary
To evaluate the incidence and pattern of bladder symptoms and sexual function change occuring after simple hysterectomy and to analyze the influence of bladder symptoms and sexual function change on quality of life of patients.
Interventions
None listed
Sponsors
Astellas Pharma Inc
Asan Medical Center
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
20 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Patients who is planed to undergo simple hysterectomy due to benign uterine disease 1. Uterine leiomyoma 2. Uterine adenomyosis 3. Endometrial hyperplasia 4. Cervical intraepithelial neoplasia (including carcinoma in situ, FIGO stage IA1 cancer) 5. Dysfunctional uterine bleeding 6. Other benign uterine disease requiring hysterectomy
Exclusion criteria
* Patients who are taking medication for overactive bladder * Patients who underwent incontinence surgery due to urinary incontinence * Acute or chronic infectious disease of urinary tract * Neurologic disease causing urinary abnormality * Previous pelvic radiation therapy * Patients who are undergoing incontinence surgery with hysterectomy * Pregnant woman
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of bladder symptoms | within 6 months after surgery |
Secondary
| Measure | Time frame |
|---|---|
| Pattern change of bladder symptoms after surgery | Baseline and within 6 months after surgery |
| Sexual function change | Baseline and within 6 months after surgery |
| Quality of life | within 6 months aftr surgery |
Countries
South Korea
Outcome results
None listed